Acellular Nature of Viruses
Viruses are acellular (not composed of cells) but must be intracellular (within a cell) to replicate.
To enter a host cell, viruses must be smaller than the host cell.
Size Comparison
E. Coli: Bacterial cell size is larger than viruses.
Red Blood Cells: Eukaryotic cells are small in size compared to bacteria and viruses.
Smallest cells in the human body.
Bacteria are significantly smaller than red blood cells.
Viruses are even smaller than bacteria; some viruses are comparable in size to ribosomes in bacterial cells.
Limit of Light Microscopes: Light microscopes can resolve up to 0.2 microns (200 nanometers), making it difficult to visualize viruses.
Electron Microscopy: To visualize small entities like viruses, electron microscopy is utilized.
Definition: Bacteriophages (phages) are viruses that infect bacteria.
Often referred to as 'bacteria eaters.'
Visual Representation
Images show bacteriophages attached to bacterial surfaces.
Colors in scans are added for visualization purposes, not accurate to real color.
Bacteriophage Structure
Composed of a capsid (head) that holds viral DNA, with tail fibers (legs) capable of puncturing bacterial cell walls.
Lytic Cycle
Attachment: Phage attaches to the host bacteria using tail fibers.
Penetration: Punctures the cell wall and injects DNA into the bacterial cytoplasm.
Host Cell Takeover: Viral DNA directs the bacterial machinery to produce more viral components, exploiting the resources of the host.
Assembly: New bacteriophage parts are assembled inside the bacterial cell.
Lysis: The bacterial cell bursts, releasing new phages to infect further bacteria.
Result of Lytic Cycle: Areas of clearance on Petri dishes where bacteria have been destroyed by phages.
Comparison with Lytic Cycle
Some phages can enter the lysogenic cycle instead of immediately destroying the host cell.
Integration: Viral DNA is integrated into the bacterial chromosome, replicating passively during bacterial cell division.
Benefits to Host: The integrated phage DNA can provide beneficial genes, aiding bacterial survival and sometimes enabling pathogenicity (e.g. diphtheria requires certain phage genes to cause disease).
Lysogenic to Lytic Switch: The phage may revert to a lytic cycle if the bacterial host experiences stress or unhealthy conditions, leading to a massive release of new phages.
Therapeutic Use: Research has explored the use of bacteriophages as a treatment for bacterial infections.
Advantages Over Antibiotics
Phages are specific to particular bacterial strains, potentially reducing collateral damage to beneficial microbiota.
Phages can evolve alongside bacteria, potentially overcoming antibiotic resistance.
Concerns with Antibiotic Use: Broad-spectrum antibiotics may harm beneficial bacteria, which phage therapy could avoid while specifically targeting harmful bacteria.
Future Directions: Increased interest in phage therapy is emerging due to rising antibiotic resistance, representing a potential sustainable alternative for treating bacterial infections.